Press Releases from DelveInsight Business Research (5349 total)
Chronic Lymphocytic Leukemia Treatment Market 2034: Clinical Trials, EMA, PDMA, …
(Albany, USA) The Chronic Lymphocytic Leukemia market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging…
Janus Kinase (JAK) Inhibitors Pipeline Assessment 2024: EMA, PDMA, FDA Approvals …
(Albany, United States) As per DelveInsight's assessment, globally, Janus Kinase (JAK) Inhibitors pipeline constitutes key companies continuously working towards developing Janus Kinase (JAK) Inhibitors treatment…
Behcet's syndrome Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) The Behcet's syndrome market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment…
Tendinopathy Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, E …
(Albany, USA) The Tendinopathy market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options…
Synovial Sarcoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approval …
(Albany, USA) The Synovial Sarcoma market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment…
Stress urinary incontinence Treatment Market 2034: Clinical Trials, EMA, PDMA, F …
(Albany, USA) The Stress urinary incontinence market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging…
Thrombotic Thrombocytopenic Purpura Treatment Market 2034: Clinical Trials, EMA, …
(Albany, USA) The Thrombotic Thrombocytopenic Purpura market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging…
KRAS Inhibitors Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
DelveInsight's "KRAS Inhibitors Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the KRAS Inhibitors, historical and forecasted epidemiology as well as…
HDAC Inhibitor Clinical Trials 2024 (Updated): EMA, PDMA, FDA Approvals, Clinica …
(Albany, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis…
Fabry Disease Market to grow at a CAGR of ~6% by 2032, analyzes DelveInsight | P …
(Albany, USA) DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fabry Disease, historical and forecasted epidemiology as well…
Secondary Hyperparathyroidism Drugs Market 2032: Clinical Trials, FDA Approvals, …
(Albany, USA) DelveInsight's "Secondary Hyperparathyroidism Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Secondary Hyperparathyroidism, historical and forecasted epidemiology as well…
Atypical Hemolytic Uremic Syndrome Drugs Market 2034: Prevalence, FDA Approvals, …
(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and…
Epilepsy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Therapies, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical…
Alpha-1 Antitrypsin Deficiency Clinical Trials 2024: FDA Approvals, Medication, …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers…
Oral Mucositis Clinical Trials 2024: FDA Approvals, Medication, Treatment Market …
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline…
Constipation Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, …
(Albany, USA) DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers…
Gastric Cancer Clinical Trials 2024: FDA Approvals, Medication, Treatment Market …
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the…
Colorectal Cancer Clinical Trials 2024: FDA Approvals, Medication, Treatment Mar …
(Albany, USA) DelveInsight's, "Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It…
CAR-T Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapi …
(Albany, USA) DelveInsight's, "CAR-T Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in CAR-T pipeline landscape. It covers the…
Ascites Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medica …
The market size of Ascites is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by…
Acute Lymphocytic Leukemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Pipel …
(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia…
HER2-Negative Breast Cancer Clinical Trials 2024: FDA Approvals, Companies, Medi …
(Albany, USA) DelveInsight's, "HER2-Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline…
Hepatocellular Carcinoma Clinical Trials 2024: FDA Approvals, Companies, Medicat …
(Albany, USA) DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It…
Neurogenic Detrusor Overactivity Treatment Market 2034: FDA Approvals, Clinical …
(Albany, USA) Neurogenic Detrusor Overactivity Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and…
Hyperlipidemia Treatment Market 2034: FDA Approvals, Clinical Trials, Prevalence …
Hyperlipidemia Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the…
Myelodysplastic Syndrome Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicat …
(Albany, USA) Myelodysplastic Syndrome companies are Novartis, Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi…
Car T Cell Therapy For Multiple Myeloma Drugs Market 2032: FDA Approvals, Clinic …
(Albany, USA) DelveInsight's "Car T Cell Therapy For Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Car T…
Pulmonary arterial hypertension Clinical Trials 2024: EMA, PDMA, FDA Approvals, …
(Albany, USA) DelveInsight's, "Pulmonary Arterial Hypertension Pipeline Insight 2024," report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Pulmonary Arterial Hypertension pipeline…
Bipolar Disorder Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, The …
(Albany, USA) DelveInsight's, "Bipolar Disorder Pipeline Insight 2024" report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the Bipolar Disorder pipeline landscape.…
HER2-Positive Breast Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medi …
(Albany, USA) DelveInsight's, "HER2 Positive Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 65+ pipeline drugs in HER2 Positive Breast…
ANCA Vasculitis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals …
[Albany, United States] - DelveInsight's "ANCA Vasculitis Market Insights, Epidemiology, and Market Forecast 2032." report offers a detailed examination of ANCA Vasculitis, covering historical and…
Alpha Thalassemia Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approva …
[Albany, United States] - DelveInsight's "Alpha Thalassemia Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Alpha Thalassemia, covering historical and…
Trigeminal Neuralgia Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Appr …
(Albany, USA) DelveInsight's "Trigeminal Neuralgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Trigeminal Neuralgia, historical and forecasted epidemiology as…
Treatment Resistant Depression Clinical Trials 2024: FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, Treatment Resistant Depression pipeline constitutes 25+ key companies continuously working towards developing 25+ Treatment Resistant Depression treatment…
Traumatic Brain Injury Clinical Trials 2024: FDA Approvals, Medication, Therapie …
(Albany, United States) "Traumatic Brain Injury Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Stuttering Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Epi …
(Albany, USA) DelveInsight's "Stuttering Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Stuttering, historical and forecasted epidemiology as well as…
Duchenne Muscular Dystrophy Treatment Market 2034: Clinical Trials, EMA, PDMA, F …
(Albany, USA) The Duchenne Muscular Dystrophy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching…
Diabetic Peripheral Neuropathy Treatment Market 2034: Clinical Trials, EMA, PDMA …
(Albany, USA) The Diabetic Peripheral Neuropathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching…
Degenerative Disk Disease Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA …
(Albany, USA) DelveInsight's "Degenerative Disk Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Degenerative Disk Disease, historical and forecasted…
Cytokine Release Syndrome Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA …
(Albany, USA) The Cytokine Release Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching…
Congestive Heart Failure Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA …
(Albany, USA) DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Congestive Heart Failure, historical and forecasted…
Neuroendocrine Tumors Clinical Trials 2024: FDA Approval, Medication, Therapies, …
(Albany, USA) DelveInsight's, "Neuroendocrine Tumors Pipeline Insight 2024" report provides comprehensive insights about 115+ companies and 130+ pipeline drugs in Neuroendocrine Tumors pipeline landscape.…
Leiomyosarcoma Clinical Trials 2024: FDA Approval, Medications, Treatment Drugs, …
(Albany, USA) DelveInsight's, "Leiomyosarcoma Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Leiomyosarcoma pipeline landscape. It covers the…
Thyroid Cancer Clinical Trials 2024: FDA Approvals, Medications, Therapies, Trea …
(Albany, USA) DelveInsight's, "Thyroid Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 51+ pipeline drugs in Thyroid Cancer pipeline landscape. It…
Small Cell Lung Cancer Clinical Trials 2024: FDA Approvals, Therapies, Treatment …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline…
Gastrointestinal Stromal Tumors (GIST) Clinical Trials 2024: FDA Approval, Medic …
(Albany, USA) DelveInsight's, "Gastrointestinal Stromal Tumors Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors (GIST)…
Global Stem Cell Market Size to grow at a CAGR of ~10% by 2030, Evaluates DelveI …
(Albany, USA) As per DelveInsight's assessment, The Stem Cell market is witnessing a positive market growth owing to the factors such as rising prevalence of…
Global Active Pharmaceutical Ingredient Market Size to grow at a CAGR of ~7% by …
(Albany, USA) According to DelveInsight's assessment, the Active Pharmaceutical Ingredient market is projected to experience significant growth in the coming years. This surge is attributed…
Global Anti-Depressant Drugs Market Expected to Experience Incremental Growth by …
(Albany, United States) As per DelveInsight's assessment, the global antidepressant drugs market growth is driven by rising depression cases worldwide, alongside a greater understanding of…
Postoperative Gastrointestinal Dysfunction Clinical Trials 2024: EMA, PDMA, FDA …
(Albany, USA) "Postoperative Gastrointestinal Dysfunction Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the…
